PROs of Patient-reported Outcomes for Nonalcoholic Fatty Liver Disease and Effects on Treatment for Nonalcoholic Steatohepatitis

Affiliations

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
² NAFLD Research Center, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California; Division of Gastroenterology, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California.

Editorial

Maya Balakrishnan et al. Clin Gastroenterol Hepatol. 2019 Sep.

. 2019 Sep;17(10):1950-1953.

doi: 10.1016/j.cgh.2019.04.018. Epub 2019 Apr 10.

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
² NAFLD Research Center, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California; Division of Gastroenterology, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California.

No abstract available

Comment on

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation.
Huber Y, Boyle M, Hallsworth K, Tiniakos D, Straub BK, Labenz C, Ruckes C, Galle PR, Romero-Gómez M, Anstee QM, Schattenberg JM; EPoS Consortium Investigators. Huber Y, et al. Clin Gastroenterol Hepatol. 2019 Sep;17(10):2085-2092.e1. doi: 10.1016/j.cgh.2018.12.016. Epub 2018 Dec 20. Clin Gastroenterol Hepatol. 2019. PMID: 30580090
Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
Younossi ZM, Stepanova M, Younossi I, Racila A. Younossi ZM, et al. Clin Gastroenterol Hepatol. 2019 Sep;17(10):2093-2100.e3. doi: 10.1016/j.cgh.2019.01.001. Epub 2019 Jan 11. Clin Gastroenterol Hepatol. 2019. PMID: 30639779